Manufacturers of feminine intimate protection products sold in France must display their composition on the packaging or instructions for use. The measure comes into force this Monday, April 1, but the decree nevertheless provides, until the end of the year, an authorized period for the disposal of stocks already placed on the market.
Estimated by INSERM at around a hundred per year, this syndrome is mainly caused by the use of internal periodic protection, namely tampons and menstrual cups. Challenged in 2015 by a petition signed by more than 300,000 people, the Procter & Gamble brand, which markets Tampax, chose to indicate the composition of its tampons.